Easton Price Earnings Ratio vs Ebt Per Ebit Analysis
Easton Pharmaceutica financial indicator trend analysis is much more than just examining Easton Pharmaceutica latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Easton Pharmaceutica is a good investment. Please check the relationship between Easton Pharmaceutica Price Earnings Ratio and its Ebt Per Ebit accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
Price Earnings Ratio vs Ebt Per Ebit
Price Earnings Ratio vs Ebt Per Ebit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Easton Pharmaceutica Price Earnings Ratio account and Ebt Per Ebit. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Easton Pharmaceutica's Price Earnings Ratio and Ebt Per Ebit is -0.38. Overlapping area represents the amount of variation of Price Earnings Ratio that can explain the historical movement of Ebt Per Ebit in the same time period over historical financial statements of Easton Pharmaceutica, assuming nothing else is changed. The correlation between historical values of Easton Pharmaceutica's Price Earnings Ratio and Ebt Per Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price Earnings Ratio of Easton Pharmaceutica are associated (or correlated) with its Ebt Per Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebt Per Ebit has no effect on the direction of Price Earnings Ratio i.e., Easton Pharmaceutica's Price Earnings Ratio and Ebt Per Ebit go up and down completely randomly.
Correlation Coefficient | -0.38 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Price Earnings Ratio
Ebt Per Ebit
Most indicators from Easton Pharmaceutica's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Easton Pharmaceutica current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.The current Selling General Administrative is estimated to decrease to about 161.2 K. The current Discontinued Operations is estimated to decrease to about 966.1 K
2016 | 2017 | 2023 | 2024 (projected) | Non Recurring | 119.2M | 113.4M | 102.1M | 93.4M | Discontinued Operations | 10.1M | 1.1M | 1.0M | 966.2K |
Easton Pharmaceutica fundamental ratios Correlations
Click cells to compare fundamentals
Easton Pharmaceutica Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Easton Pharmaceutica fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.6M | 10.1M | 17.2M | 10.2M | 11.7M | 12.3M | |
Total Current Liabilities | 245.8K | 792.0K | 1.5M | 620.8K | 558.7K | 557.7K | |
Other Liab | 48.3K | 46.2K | 161.1K | 180.2K | 162.1K | 250.1K | |
Accounts Payable | 30.8K | 568.5K | 845.1K | 255.8K | 230.2K | 327.4K | |
Total Liab | 2.5M | 3.0M | 10.1M | 3.3M | 3.8M | 2.0M | |
Total Stockholder Equity | 160.0K | 7.1M | 7.1M | 6.9M | 7.9M | 8.3M | |
Other Assets | 1.8M | 742.6K | 95.8K | 94.0K | 84.6K | 80.4K | |
Net Tangible Assets | (465.0K) | (1.1M) | (1.1M) | (1.0M) | (930.6K) | (884.0K) | |
Retained Earnings | (39.1M) | (39.2M) | (39.6M) | (39.8M) | (35.8M) | (37.6M) | |
Long Term Debt | 2.2M | 2.2M | 8.5M | 2.5M | 2.9M | 1.9M | |
Total Current Assets | 198K | 66.3K | 249.8K | 426.3K | 383.7K | 234.0K | |
Long Term Investments | 926.6M | 1.1M | 1.7M | 1.7M | 1.6M | 1.5M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Easton Pharmaceutica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Easton Pharmaceutica's short interest history, or implied volatility extrapolated from Easton Pharmaceutica options trading.
Pair Trading with Easton Pharmaceutica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Easton Pharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Easton Pharmaceutica will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Easton Pharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Easton Pharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Easton Pharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Easton Pharmaceutica to buy it.
The correlation of Easton Pharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Easton Pharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Easton Pharmaceutica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Easton Pharmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Easton Stock analysis
When running Easton Pharmaceutica's price analysis, check to measure Easton Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easton Pharmaceutica is operating at the current time. Most of Easton Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Easton Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easton Pharmaceutica's price. Additionally, you may evaluate how the addition of Easton Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Easton Pharmaceutica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.001 | Return On Assets (0.01) | Return On Equity (0.03) |
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.